Pharmaceutical M&A
Merck’s Strategic Gambit: Why a Potential Deal for Cidara’s Flu Drug Could Reshape Preventative Medicine and Your Portfolio
Merck’s potential acquisition of Cidara Therapeutics signals a major shift in flu prevention, impacting healthcare, finance, and the broader economy.
High-Stakes Finance Unpacked: A PE Giant’s UK Nightmare, a Shadow Banking Mystery, and a Big Pharma Showdown
A deep dive into Cinven’s UK crisis, a fintech lending mystery involving a Utah bank, and Novo Nordisk’s strategic challenge to Pfizer.